StemCyte, Inc.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition (NCT07184385) | StemCyte, Inc. | 2026-03-31 |
| Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke (AIS) (NCT06040476) | StemCyte, Inc. | 2025-09-01 |
| Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients with Post-COVID Syndrome (NCT05682560) | StemCyte, Inc. | 2023-05-04 |
| Umbilical Cord Blood Cell (MC001) Transplant Into Injured Spinal Cord Followed by the Locomotor Training (NCT03979742) | StemCyte, Inc. | 2022-02-22 |
Track StemCyte, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.